Knowledge Sharing Session : Pahami Metabolisme Tubuh Kita

Mengapa tubuh kita menjadi cepat gemuk? Apa yang membuat kita tetap kurus walau banyak makan? Mengapa kita bisa sakit atau sehat? Ayo cari tahu proses proses perubahan fisik atau kimia yang terjadi pada tubuh!

Knowledge Sharing Session : Basic Vocal Techniques - Sing Like a Pro

Ibaratnya Tubuhmu adalah instrumenmu, kamu harus merawat tubuhmu sebagaimana seorang pemain biola merawat biolanya.

Advanced nasopharyngeal carcinoma in children

Nasopharyngeal carcinoma (NPC) is the most familiar cancer originating in the nasopharynx, and not uncommonly found in the head and neck region in adults. Under appropriate and effective treatment, the outcome subsequent to medical intervention can be relatively good in adults with nasopharyngeal carcinoma. However, NPC is very uncommon in children younger than 10 years, and its incidence incre…

Peripartum Cardiomyopathy

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

-

Palonosetron in pediatric patients: A single-center, retrospective evaluation…

Clinical practice guidelines (CPGs) recommending palonosetron for the prevention and management of chemotherapy-induced nausea and vomiting (CINV) were adapted for use at our institution. Palonosetron was restricted for use in patients experiencing breakthrough CINV and receiving highly emetogenic chemotherapy (HEC) or undergoing stem cell transplant conditioning and in patients with refract…

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for pre…

d Palonosetron is a second-generation 5-hydroxytryptamine 3 (5-HT3)-receptor antagonist that has shown better effi cacy than ondansetron and dolasetron in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic chemotherapy, and similar effi cacy to ondansetron in preventing CINV in patients receiving highly emetogenic chemotherapy. In this p…

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induc…

Palonosetron, a 5-hydroxytryptamine 3 receptor antagonist (5-HT3RA) with a strong binding affinity and long half-life, has been used in numerous trials for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV). We systematically reviewed the efficacy and safety of palonosetron compared to other 5-HT3RAs in CINV prophylaxis.

Multicenter nonrandomized trial of ramosetron versus palonosetron in controll…

Chemotherapy-induced nausea and vomiting (CINV) have a negative impact on patients’ quality of life and frequently pointed to as a major factor for treatment abandonment. Serotonin (5-HT3) receptor antagonist is considered as key treatment for CINV. Ramosetron and palonosetron are recently developed 5-HT3 receptor antagonists and known as more superior than other first-generation 5-HT3 …

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting …

Although all first-generation 5-HT3 receptor antagonists demonstrate efficacy in preventing acute chemotherapy-induced nausea and vomiting (CINV), effective prevention of delayed CINV has not yet been achieved. This study compared the efficacy and tolerability of palonosetron, a novel, second-generation 5-HT3 receptor antagonist, with ondansetron.

Comparison of the Prophylactic Antiemetic Efficacy of Aprepitant Plus Palonos…

We compared the antiemetic efficacy of aprepitant plus palonosetron versus aprepitant plus ramosetron in patients after laparoscopic cholecystectomy. A total of 88, nonsmoking, female patients undergoing laparoscopic cholecystectomy were randomly allocated to 2 groups of 44 each who received palonosetron 0.075 mg (aprepitant plus palonosetron group) and ramosetron 0.3 mg (aprepitant plus ramos…